Source: DGNews | Posted 8 years ago
FDA Grants Priority Review to Eloxatin (Oxaliplatin) for First-Line Treatment of Metastatic Colorectal Cancer
Tags:
PARIS, FRANCE -- September 17, 2003 -- Sanofi-Synthelabo announced today that the U.S. Food and Drug Administration (FDA) has granted a six-month priority review to Eloxatin
Comments